Minimum 10-year follow-up of a prospective FDA IDE cohort that underwent reverse shoulder arthroplasty with a lateralized center-of-rotation implant and peripheral locking screw baseplate fixation for end-stage rotator cuff deficiency. Reports implant survivorship, functional outcomes, and radiographic findings at a decade post-op.
When counseling patients on RSA for rotator cuff arthropathy, this series supports that functional gains are durable at a decade with a lateralized implant and locking screw baseplate fixation — expect modest motion decline with age but stable pain relief and >90% implant survival.
Perioperative failures (instability, fracture) remain the primary revision drivers, not late mechanical loosening.
Minimum 10-year follow-up of a prospective FDA IDE cohort that underwent reverse shoulder arthroplasty with a lateralized center-of-rotation implant and peripheral locking screw baseplate fixation for end-stage rotator cuff deficiency. Reports implant survivorship, functional outcomes, and radiographic findings at a decade post-op.
When counseling patients on RSA for rotator cuff arthropathy, this series supports that functional gains are durable at a decade with a lateralized implant and locking screw baseplate fixation — expect modest motion decline with age but stable pain relief and >90% implant survival.
Perioperative failures (instability, fracture) remain the primary revision drivers, not late mechanical loosening.